Lymphangiogenic growth factors, in particular vascular endothelial growth factor C (VEGF-C), are derived from tumor cells and promote tumor lymphangiogenesis by activating the endothelial receptor tyrosine kinases VEGFR2 and VEGFR3 (13). The gene discussed is VEGFC; the disease is neoplasm.